Literature DB >> 26490055

A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis.

S R Dorajoo, W J H Tan, S X Koo, W S Tan, M H Chew, C L Tang, H L Wee, C W Yap.   

Abstract

BACKGROUND: Stage IV colorectal cancer patients with unresectable metastasis who undergo elective primary tumour resection experience heterogeneous post-operative survival. We aimed to develop a scoring model for predicting post-operative survival using pre-operative variables to identify patients who are least likely to experience extended survival following the procedure.
METHODS: Survival data were collected from stage IV colorectal cancer patients who had undergone elective primary tumour resection between January 1999 and December 2007. Coefficients of significant covariates from the multivariate Cox regression model were used to compute individual survival scores to classify patients into three prognostic groups. A survival function was derived for each group via Kaplan-Meier estimation. Internal validation was performed.
RESULTS: Advanced age (hazard ratio, HR 1.43 (1.16-1.78)); poorly differentiated tumour (HR 2.72 (1.49-5.04)); metastasis to liver (HR 1.76 (1.33-2.33)), lung (HR 1.37 (1.10-1.71)) and bone (HR 2.08 ((1.16-3.71)); carcinomatosis (HR 1.68 (1.30-2.16)); hypoalbuminaemia (HR 1.30 (1.04-1.61) and elevated carcinoembryonic antigen levels (HR 1.89 (1.49-2.39)) significantly shorten post-operative survival. The scoring model separated patients into three prognostic groups with distinct median survival lengths of 4.8, 12.4 and 18.6 months (p < 0.0001). Internal validation revealed a concordance probability estimate of 0.65 and a time-dependent area under receiver operating curve of 0.75 at 6 months. Temporal split-sample validation implied good local generalizability to future patient populations (p < 0.0001).
CONCLUSION: Predicting survival following elective primary tumour resection using pre-operative variables has been demonstrated with the scoring model developed. Model-based survival prognostication can support clinical decisions on elective primary tumour resection eligibility.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26490055     DOI: 10.1007/s00384-015-2419-z

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  33 in total

1.  How aggressive should we be in patients with stage IV colorectal cancer?

Authors:  Li-Jen Kuo; Shuh-Yan Leu; Mei-Ching Liu; James Jer-Min Jian; Skye Hongiun Cheng; Chung-Ming Chen
Journal:  Dis Colon Rectum       Date:  2003-12       Impact factor: 4.585

2.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

Review 3.  Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.

Authors:  D G Altman; B Lausen; W Sauerbrei; M Schumacher
Journal:  J Natl Cancer Inst       Date:  1994-06-01       Impact factor: 13.506

4.  Elective palliative resection of incurable stage IV colorectal cancer: who really benefits from it?

Authors:  Renato Costi; Davide Di Mauro; Licia Veronesi; Andrea Ardizzoni; Pierfranco Salcuni; Luigi Roncoroni; Leopoldo Sarli; Vincenzo Violi
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

Review 5.  Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer.

Authors:  Roberto Cirocchi; Stefano Trastulli; Iosief Abraha; Nereo Vettoretto; Carlo Boselli; Alessandro Montedori; Amilcare Parisi; Giuseppe Noya; Cameron Platell
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

6.  Palliative operations for colorectal cancer.

Authors:  J Mäkelä; K Haukipuro; S Laitinen; M I Kairaluoma
Journal:  Dis Colon Rectum       Date:  1990-10       Impact factor: 4.585

7.  Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases.

Authors:  S Benoist; K Pautrat; E Mitry; P Rougier; C Penna; B Nordlinger
Journal:  Br J Surg       Date:  2005-09       Impact factor: 6.939

8.  The Role of Surgery for Asymptomatic Primary Tumors in Unresectable Stage IV Colorectal Cancer.

Authors:  Young Wan Kim; Ik Yong Kim
Journal:  Ann Coloproctol       Date:  2013-04-30

9.  Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis.

Authors:  Min Sung Kim; MinKyu Chung; Joong Bae Ahn; Chang Woo Kim; Min Soo Cho; Sang Joon Shin; Se Jin Baek; Hyuk Hur; Byung Soh Min; Seung Hyuk Baik; Nam Kyu Kim
Journal:  J Surg Oncol       Date:  2014-03-26       Impact factor: 3.454

10.  [Clinical features and prognosis in 104 colorectal cancer patients with bone metastases].

Authors:  Ruo-xi Hong; Qiu-ju Lin; Jian Luo; Zhen Dai; Wen-na Wang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2013-10
View more
  2 in total

1.  Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer.

Authors:  Ellen G Engelhardt; Dóra Révész; Hans J Tamminga; Cornelis J A Punt; Miriam Koopman; Bregje D Onwuteaka-Philipsen; Ewout W Steyerberg; Henrica C W de Vet; Veerle M H Coupé
Journal:  BMC Med Inform Decis Mak       Date:  2018-12-14       Impact factor: 2.796

2.  Individualized prediction of survival benefit from primary tumor resection for patients with unresectable metastatic colorectal cancer.

Authors:  Yi Yang; Yujie Lu; Wen Jiang; Jinzhou Zhu; Su Yan
Journal:  World J Surg Oncol       Date:  2020-08-03       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.